Erratum: Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population (Journal of Viral Hepatitis (2014) 21 (925-929) DOI: 10.1111/jvh.12302));Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population

Journal of Viral Hepatitis

Volumn 21, Issue 12, 2014, Pages 925-929

  Sui, M ^a   Wu, R ^a   Hu, X ^b   Zhang, H ^c   Jiang, J ^a   Yang, Y ^a   Niu, J ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Second Hospital of Heilongjiang Province   (China)

^c Xixi Hospital of Hangzhou   (China)

Author keywords

autoimmune hepatitis; hepatitis B surface antigen positive rate; primary biliary cirrhosis; systemic lupus erythematosus; ulcerative colitis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; APPENDICITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; INGUINAL HERNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIMARY BILIARY CIRRHOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; ADOLESCENT; AUTOIMMUNE DISEASES; BLOOD; CHILD; CHINA; COMORBIDITY; COMPLICATION; INFANT; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; CHINA; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; INFANT; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84910666583     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12466     Document Type: Erratum

References (29)

1. Liu J, Fan D,. Hepatitis B in China. Lancet 2007; 369 (9573): 1582-1583.
2. Liaw YF, Chu CM,. Hepatitis B virus infection. Lancet 2009; 373 (9663): 582-592.
3. Dienstag JL,. Hepatitis B virus infection. N Engl J Med 2008; 359 (14): 1486-1500.
4. Kane M,. Global programme for control of hepatitis B infection. Vaccine 1995; 13 (Suppl 1): S47-S49.
5. Liang X, Bi S, Yang W, et al,. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27 (47): 6550-6557.
6. Kim BK, Revill PA, Ahn SH,. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther 2011; 16 (8): 1169-1186.
7. Dandri M, Locarnini S,. New insight in the pathobiology of hepatitis B virus infection. Gut 2012; 61 (Suppl 1): i6-i17.
8. Walsh R, Locarnini S,. Hepatitis B precore protein: pathogenic potential and therapeutic promise. Yonsei Med J 2012; 53 (5): 875-885.
9. Herkel J, Carambia A,. Let it B in viral hepatitis? J Hepatol 2011; 55 (1): 5-7.
10. Berkun Y, Zandman-Goddard G, Barzilai O, et al,. Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009; 18 (13): 1129-1135.
11. Ram M, Anaya JM, Barzilai O, et al,. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 2008; 7 (8): 621-625.
12. Lidar M, Lipschitz N, Langevitz P, et al,. The infectious etiology of vasculitis. Autoimmunity 2009; 42 (5): 432-438.
13. Arnson Y, Amital H, Guiducci S, et al,. The role of infections in the immunopathogensis of systemic sclerosis-evidence from serological studies. Ann N Y Acad Sci 2009; 1173: 627-632.
14. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr,. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974; 17 (1): 1-10.
15. Looi LM, Prathap K,. Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. Histopathology 1982; 6 (2): 141-147.
16. Lidar M, Langevitz P, Barzilai O, et al,. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 2009; 1173: 640-648.
17. Venkataseshan VS, Lieberman K, Kim DU, et al,. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course. Medicine 1990; 69 (4): 200-216.
18. Zhao J, Qiu M, Li M, Lu C, Gu J,. Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China. Rheumatol Int 2010; 30 (12): 1565-1570.
19. Ziegenfuss JF Jr, Byrne EB, Stoloff IL, Burka ER,. Australia antigen in systemic lupus erythematosus. Lancet 1972; 1 (7754): 800.
20. Shorey J, Cheatum DE, Combes B, Ziff M,. Hepatitis B antigen and antibody in patients with systemic lupus erythematosus. Arthritis Rheum 1974; 17 (5): 583-589.
21. Abu-Shakra M, El-Sana S, Margalith M, Sikuler E, Neumann L, Buskila D,. Hepatitis B and C viruses serology in patients with SLE. Lupus 1997; 6 (6): 543-544.
22. Santoro D, Stella M, Montalto G, Castellino S,. Lupus nephritis after hepatitis B vaccination: an uncommon complication. Clin Nephrol 2007; 67 (1): 61-63.
23. Finielz P, Lam-Kam-Sang LF, Guiserix J,. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant 1998; 13 (9): 2420-2421.
24. McMahon BJ, Helminiak C, Wainwright RB, Bulkow L, Trimble BA, Wainwright K,. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1992; 92 (3): 254-256.
25. Stubgen JP,. Immune-mediated myelitis following hepatitis B vaccination. Autoimmun Rev 2012; 12 (2): 144-149.
26. Shi YH, Shi CH,. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 2009; 15 (25): 3099-3105.
27. Bertoletti A, Gehring AJ,. The immune response during hepatitis B virus infection. J Gen Virol 2006; 87 (Pt 6): 1439-1449.
28. Maini MK, Schurich A,. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J Hepatol 2010; 52 (4): 616-619.
29. Thimme R, Wieland S, Steiger C, et al,. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77 (1): 68-76.